Kura Oncology Inc
KURA
$13.25+0.76%
End of day · as of Sep 6, 2026, 1:45 AM ET
Mkt cap
$861.12M
EV/Sales
10.7
P/E ratio
N/A
FY2025 Revenue
$67.48M
EPS (TTM)
$-3.37
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-412.95%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported KURA revenue for 2025-12-31 was $67.5M. Net income was -$278.7M. Revenue was up 25.2% from 2024-12-31 to 2025-12-31. KURA currently screens at market cap $861.1M.
Use this KURA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KURA income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Kura Oncology Inc (KURA) is a biotechnology company in the Healthcare sector.
Latest cached Kura Oncology Inc (KURA) revenue for Dec 31, 2025 was $67.5M. Net income was -$278.7M. Statements: https://lician.com/financials/kura
Kura Oncology Inc (KURA) market capitalization is $861.1M on the latest cached snapshot.
Kura Oncology Inc (KURA) cached previous close $13.15; day range $12.89 – $13.27; volume 1,311,787. Session quote: https://lician.com/quote/kura
Kura Oncology Inc (KURA) latest cached earnings event is "KURA earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KURA filing is 8-K · Sep 9, 2026. Filings: https://lician.com/sec/kura